| Antiviral | EC50 ratio | Phenotype | Strain | Source | Marker | Assay | Reference |
|---|---|---|---|---|---|---|---|
| Ganciclovir | 4.20 | Intermediate level resistance | Details | Identification of resistance-associated HCMV UL97- and UL54-mutations and a UL97-polymporphism with impact on phenotypic drug-resistance. (Jul 2016) | |||
| Cidofovir | 8.49 | High level resistance | Details | Identification of resistance-associated HCMV UL97- and UL54-mutations and a UL97-polymporphism with impact on phenotypic drug-resistance. (Jul 2016) | |||
| Foscarnet | 1.22 | No resistance | Details | Identification of resistance-associated HCMV UL97- and UL54-mutations and a UL97-polymporphism with impact on phenotypic drug-resistance. (Jul 2016) |
| Mutant | Resistances |
|---|---|
| L516R |
Ganciclovir:
|
| L516R |
Cidofovir:
|
| L516R |
Foscarnet:
|